MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    The Transcriptomic, Neurotransmitter, and Cell Type Signatures Underlying Pure Fatigue in Early-stage Parkinson’s Disease

    Y. Xiao, S. Wang, Y. Hou, R. Ou, C. Li, W. Song, X. Shi, X. Zhu, H. Shang (Chengdu, China)

    Objective: This study elucidates spatiotemporal functional connectivity of pure fatigue in early Parkinson’s disease (PD) and uncovering underlying gene expression profiles. Background: Fatigue is a…
  • 2026 International Congress

    Nutritional Status as a Modifiable Determinant of Clinical Outcomes in Parkinson’s Disease: A 12-Month Longitudinal Study in Patients Treated with DBS and L-Dopa

    N. Ayo Mentxakatorre, M. Acera Gil, C. Juanes-Moreno, T. Fernandez-Valle, B. Tijero, M. Ruiz-Lopez, JC. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)

    Objective: To analyze longitudinal changes in nutritional status in Parkinson’s disease (PD) patients treated with deep brain stimulation (DBS), compared with pharmacological therapy (L-dopa) and to…
  • 2026 International Congress

    Visualization of Small Brainstem Nuclei With the Ultra-High Performance NeuroEXPLORER PET Camera: a Comparison Study Using 18F-AV133

    N. Prakash, R. Gunn, G. Rizzo, G. Searle, Z. Fan, J. Eberling, G. Tamagnan, J. Seibyl, K. Marek (New Haven, USA)

    Objective: To compare the performance of 18F-AV133 between NeuroEXPLORER (NX) and standard resolution Siemens Biography (mCT) positron emission tomography (PET) cameras in people with Parkinson's…
  • 2026 International Congress

    Early Complement Activation Prunes Inhibitory Synapses in Prodromal Synucleinopathy Independent from Lewy Pathology.

    S. Rumpf, F. Strübing, K. Nalbach, C. Vargi, S. Lichtenthaler, P. Parchi, P. Gao, W. Chen, M. Brendel, J. Gnörich, A. Bernhardt, G. Höglinger, J. Herms, T. Koeglsperger (Munich, Germany)

    Objective: To identify early molecular and cellular changes associated with dopaminergic neuron vulnerability and synuclein pathology across different disease contexts. Background: Parkinson’s disease (PD) is…
  • 2026 International Congress

    Temporal Ordering of Biomarker Abnormality Events Leading to Cognitive Impairment in Parkinson’s Disease: A Disease Event-Based Model Analysis of the PPMI Cohort

    A. Negida (Richmond, USA)

    Objective: To estimate the temporal ordering of multimodal biomarker abnormality events leading to cognitive impairment in PD using a Disease Event-Based Model (DEBM), incorporating clinical,…
  • 2026 International Congress

    A Randomized Controlled Trial Evaluating Ankle Pump Combined with Compression Abdominal Belts on Orthostatic Hypotension in Patients with Parkinson’s Disease

    Z. Ruan, YY. Zhang, WH. Guo, JY. Liu (Beijing, China)

    Objective: To investigate the short-term efficacy of ankle pump exercise combined with automated compression abdominal belts on orthostatic hypotension (OH) and orthostatic intolerance symptoms in…
  • 2026 International Congress

    Beta and Gamma Local Field Potentials in Chronic Deep Brain Stimulation for Parkinson’s Disease: Programming Implications from a Systematic Review

    KS. Thu Aung, S. Lane, J. Osman-Farah, A. Macerollo (Liverpool, United Kingdom)

    Objective: To define distinct clinical roles of beta- and gamma-band local field potential (LFP) biomarkers in chronic deep brain stimulation (DBS) for Parkinson’s disease (PD)…
  • 2026 International Congress

    Prediction of Cognitive Decline After STN-DBS in Parkinson’s Disease Using Preoperative Electroencephalography and a Deep Learning Model

    K. Iwami, K. Eguchi, S. Shirai, H. Yaguchi, I. Yabe (Sapporo, Japan)

    Objective: To determine whether preoperative electroencephalography (EEG) combined with deep learning can predict cognitive decline 1 year after subthalamic deep brain stimulation (STN-DBS) in patients…
  • 2026 International Congress

    Disassembly of α-Synuclein Aggregates by the All-D-peptide PRI-101: Preclinical Efficacy in Vitro and in Vivo.

    M. Sevenich, M. Feja, J. Jarazo, S. Reithofer, K. Korostov, S. Schemmert, F. Charbgoo, M. Wendt, G. Tamgüney, J. Schwamborn, F. Richter, D. Willbold, A. Willuweit (40225, Germany)

    Objective: To develop a disease-modifying therapy for Parkinson’s disease (PD) and related synucleinopathies by eliminating intracellular, toxic, and seeding-competent aggregate species of α-synuclein (α-syn). Background:…
  • 2026 International Congress

    To Protect Life and Safeguard Autonomy: Ambiguous Expressions of the Will to Live

    J. Braun, B. Schmitz-Luhn ()

    Objective: This study examines the ethical and legal criteria for determining a patient’s authentic will in late-stage Parkinson’s disease when refusal of life-sustaining measures occurs…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley